We have located links that may give you full text access.
Improving anti thrombogenicity of nanofibrous polycaprolactone through surface modification.
Journal of Biomaterials Applications 2019 June 11
To improve anti thrombogenicity of polycaprolactone, nanofibrous mat of this synthetic polymer is prepared by electrospinning method. Subsequently, plain electrospun nanofibrous polycaprolactone was treated by RF oxygen plasma to initiate the graft copolymerization with acrylamide monomers. The surface morphology and average fiber diameter of plain electrospun nanofibrous polycaprolactone were determined by scanning electron microscopy technique. The chemical composition and surface characteristics of the samples were examined by static contact angle measurements, and attenuated total reflectance Fourier transfer infrared (ATR-FTIR) spectroscopy. Atomic force microscopy was employed to investigate the effect of plasma treatment and graft copolymerization on the surface roughness and topography of the samples. Mechanical properties were measured from the stress-strain curve. The amount of platelet adhesion was observed by scanning electron microscopy images. Results indicate that the polycaprolactone synthetic polymer was successfully electrospun with a nanofibrous micro structure. The ATR-FTIR spectrum confirmed the influence of RF oxygen plasma treatment and graft copolymerization. Contact angle outcomes exhibited a massive improvement in the hydrophilic property of the polycaprolactone-plasma-acrylamide sample, and the surface roughness of this sample also decreased dramatically as atomic force microscopy results showed. The mechanical property of the polycaprolactone-plasma-acrylamide sample shows a negligible reduction in comparison with plain electrospun polycaprolactone. The polycaprolactone-plasma-acrylamide sample possesses proper values of mechanical properties compared to natural blood vessels. The SEM images of polycaprolactone, polycaprolactone-plasma, and polycaprolactone-plasma-acrylamide revealed no adhesion of natural platelets for polycaprolactone-plasma-acrylamide. Thus, the polycaprolactone-plasma-acrylamide vascular prosthesis is fabricated and post processed with sufficient surface properties and anti thrombogenicity.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app